武汉云克隆科技股份有限公司

表皮生长因子受体(EGFR)检测试剂盒(酶联免疫吸附试验法)

ELISA Kit for Epidermal Growth Factor Receptor (EGFR)

ErbB-1; ErbB1; ER1; ERB-B1; MENA; HER1; Erythroblastic Leukemia Viral(v-Erb-B)oncogene Homolog,Avian; Proto-oncogene c-ErbB-1; Receptor tyrosine-protein kinase erbB-1

  • 表皮生长因子受体(EGFR)检测试剂盒(酶联免疫吸附试验法)产品包装(模拟)
  • 表皮生长因子受体(EGFR)检测试剂盒(酶联免疫吸附试验法)产品包装(模拟)
  • 表皮生长因子受体(EGFR)检测试剂盒(酶联免疫吸附试验法)实验结果图
  • SEA757Hu.jpg标准曲线图
  • Certificate通过ISO 9001、ISO 13485质量体系认证

特异性

本试剂盒用于检测表皮生长因子受体(EGFR)，经检测与其它相似物质无明显交叉反应。
由于受到技术及样本来源的限制，不可能完成对所有相关或相似物质交叉反应检测，因此本试剂盒有可能与未经检测的其它物质有交叉反应。

回收率

分别于定值血清及血浆样本中加入一定量的表皮生长因子受体(EGFR)（加标样品），重复测定并计算其均值，回收率为测定值与理论值的比率。

样本回收率范围(%)平均回收率(%)
serum(n=5)94-10197
EDTA plasma(n=5)93-10197
heparin plasma(n=5)99-105102

精密度

精密度用样品测定值的变异系数CV表示。CV(%) = SD/mean×100
批内差：取同批次试剂盒对低、中、高值定值样本进行定量检测,每份样本连续测定20 次，分别计算不同浓度样本的平均值及SD值。
批间差：选取3个不同批次的试剂盒分别对低、中、高值定值样本进行定量测定，每个样本使用同一试剂盒重复测定8次，分别计算不同浓度样本的平均值及SD值。
批内差： CV<10%
批间差： CV<12%

线性

在定值血清及血浆样本内加入适量的表皮生长因子受体(EGFR)，并倍比稀释成1:2，1:4，1:8，1:16的待测样本，线性范围即为稀释后样本中表皮生长因子受体(EGFR)含量的测定值与理论值的比率。

样本1:21:41:81:16
serum(n=5)80-93%87-94%81-88%92-102%
EDTA plasma(n=5)78-101%92-101%80-94%85-94%
heparin plasma(n=5)85-92%87-96%81-94%95-103%

稳定性

经测定，试剂盒在有效期内按推荐温度保存，其活性降低率小于5%。
为减小外部因素对试剂盒破坏前后检测值的影响，实验室的环境条件需尽量保持一致，尤其是实验室内温度、湿度及温育条件。其次由同一实验员来进行操作可减少人为误差。

实验流程

1. 实验前标准品、试剂及样本的准备；
2. 加样（标准品及样本）100µL，37°C孵育1小时；
3. 吸弃，加检测溶液A100µL，37°C孵育1小时；
4. 洗板3次；
5. 加检测溶液B100µL，37°C孵育30分钟；
6. 洗板5次；
7. 加TMB底物90µL，37°C孵育10-20分钟；
8. 加终止液50µL，立即450nm读数。

实验原理

将表皮生长因子受体(EGFR)抗体包被于96孔微孔板中，制成固相载体，向微孔中分别加入标准品或标本，其中的表皮生长因子受体(EGFR)与连接于固相载体上的抗体结合，然后加入生物素化的表皮生长因子受体(EGFR)抗体，将未结合的生物素化抗体洗净后，加入HRP标记的亲和素，再次彻底洗涤后加入TMB底物显色。TMB在过氧化物酶的催化下转化成蓝色，并在酸的作用下转化成最终的黄色。颜色的深浅和样品中的表皮生长因子受体(EGFR)呈正相关。用酶标仪在450nm波长下测定吸光度(O.D.值)，计算样品浓度。

相关产品

编号适用物种：Homo sapiens (Human，人)应用(仅供研究使用，不用于临床诊断！)
APA757Hu01表皮生长因子受体(EGFR)活性蛋白Cell culture; Activity Assays.
APA757Hu02表皮生长因子受体(EGFR)活性蛋白Cell culture; Activity Assays.
APA757Hu62表皮生长因子受体(EGFR)活性蛋白Cell culture; Activity Assays.
RPA757Hu01表皮生长因子受体(EGFR)重组蛋白Positive Control; Immunogen; SDS-PAGE; WB.
APA757Hu61表皮生长因子受体(EGFR)活性蛋白Cell culture; Activity Assays.
EPA757Hu62表皮生长因子受体(EGFR)真核蛋白Positive Control; Immunogen; SDS-PAGE; WB.
RPA757Hu02表皮生长因子受体(EGFR)重组蛋白Positive Control; Immunogen; SDS-PAGE; WB.
EPA757Hu61表皮生长因子受体(EGFR)真核蛋白Positive Control; Immunogen; SDS-PAGE; WB.
PAA757Hu06表皮生长因子受体(EGFR)多克隆抗体WB; IHC; ICC; IP.
PAA757Hu02表皮生长因子受体(EGFR)多克隆抗体WB; IHC; ICC/IF
PAA757Hu01表皮生长因子受体(EGFR)多克隆抗体WB; ICC/IF
FAA757Hu51抗表皮生长因子受体(EGFR)多克隆抗体(别藻蓝蛋白标记)FCM
MAA757Hu27表皮生长因子受体(EGFR)单克隆抗体WB; IHC; ICC; IP.
MAA757Hu29表皮生长因子受体(EGFR)单克隆抗体WB; IHC; ICC; IP.
RAA757Hu21表皮生长因子受体(EGFR)重组抗体WB; IF; ICC; IHC; IP; FCM.
MAA757Hu21表皮生长因子受体(EGFR)单克隆抗体WB; IHC
MAA757Hu23表皮生长因子受体(EGFR)单克隆抗体WB; ICC/IF
MAA757Hu24表皮生长因子受体(EGFR)单克隆抗体WB; IHC; ICC; IP.
MAA757Hu25表皮生长因子受体(EGFR)单克隆抗体WB; IHC; ICC; IP.
MAA757Hu22表皮生长因子受体(EGFR)单克隆抗体WB; IHC
SEA757Hu表皮生长因子受体(EGFR)检测试剂盒(酶联免疫吸附试验法)Enzyme-linked immunosorbent assay for Antigen Detection.
HEA757Hu表皮生长因子受体(EGFR)检测试剂盒(酶联免疫吸附试验法,高敏型)Enzyme-linked immunosorbent assay for Antigen Detection.
AEA757Hu抗表皮生长因子受体抗体(Anti-EGFR)检测试剂盒(酶联免疫吸附试验法)Enzyme-linked immunosorbent assay for Antibody Detection.
LMA757Hu表皮生长因子受体(EGFR)等多因子检测试剂盒(流式荧光发光法)FLIA Kit for Antigen Detection.

参考文献

杂志参考文献
Thoracic CancerNimotuzumab combined with gemcitabine and cisplatin as second-line chemotherapy for advanced non-small-cell lung cancer[Wiley: source]
J Cent Nerv Syst Dis.?Increased Epidermal Growth Factor Receptor (EGFR) Associated with Hepatocyte Growth Factor (HGF) and Symptom Severity in Children with Autism …[Pubmed:25249767]
Mol Cancer TherGC1118, an anti-EGFR antibody with a distinct binding epitope and superior inhibitory activity against high-affinity EGFR ligands[PubMed: 26586721]
Cell Death Dis. LINC01225 promotes occurrence and metastasis of hepatocellular carcinoma in an epidermal growth factor receptor-dependent pathway[Pubmed:26938303]
analytica chimica acta Microfluidic immunosensor based on mesoporous silica platform and CMK-3/poly-acrylamide-co-methacrylate of dihydrolipoic acid modified gold electrode for cancer biomarker detection.[pubmed:28335979]
TalantaEGFR detection in extracellular vesicles of breast cancer patients through immunosensor based on silica-chitosan nanoplatform[Doi: 10.1016/j.talanta.2018.10.016]
Bioorganic ChemistryDesign, synthesis, molecular docking and biological activity evaluation of some novel indole derivatives as potent anticancer active agents and apoptosis inducers[Pubmed: 30665034]
Journal of enzyme inhibition and medicinal chemistryNovel thienopyrimidine derivatives as dual EGFR and VEGFR-2 inhibitors: design, synthesis, anticancer activity and effect on cell cycle profile[Pubmed: 30919701]
Bioorganic ChemistryDesign and synthesis of new benzoxazole/benzothiazole-phthalimide hybrids as antitumor-apoptotic agents[]
Bioorganic ChemistrySynthesis and anticancer activity of bis-benzo [d][1, 3] dioxol-5-yl thiourea derivatives with molecular docking study[Pubmed: 31288134]
Oxidative Medicine and Cellular LongevityEvaluation of the Effect Derived from Silybin with Vitamin D and Vitamin E Administration on Clinical, Metabolic, Endothelial Dysfunction, Oxidative Stress Parameters …[Pubmed: 31737175]
NeoplasiaPatient-derived xenograft (PDX) models of colorectal carcinoma (CRC) as a platform for chemosensitivity and biomarker analysis in personalized medicine[Pubmed: 33212364]
Association between Serum Epidermal Growth Factor Receptor and Cyclooxygenase-2 Levels in Patients with Non-small Cell Carcinoma of Lung[]
Synthesis, EGFR-TK inhibition and anticancer activity of new quinoxaline derivatives[]
IMMUNOLOGIC RESEARCHHumoral immune response to epidermal growth factor receptor in lung cancer[33495907]
European Journal of Medicinal ChemistryPyrazolo[3,4-d]pyrimidine-based dual EGFR T790M/HER2 inhibitors: Design, synthesis, structure¨Cactivity relationship and biological activity as potential antitumor and anticonvulsant agents[33545637]
Journal of Molecular StructureDesign, synthesis, antiproliferative evaluation, and molecular docking study of new quinoxaline derivatives as apoptotic inducers and EGFR inhibitors[]
ACS Appl Mater InterfacesEmitter–Quencher Pair of Single Atomic Co Sites and Monolayer Titanium Carbide MXenes for Luminol Chemiluminescent Reactions[34914377]
Bioorganic ChemistryDiscovery of new pyrimido [5, 4-c] quinolines as potential antiproliferative agents with multitarget actions: Rapid synthesis, docking, and ADME studies[Pubmed:35219045]